nodes	percent_of_prediction	percent_of_DWPC	metapath
Midodrine—ADRA1D—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0421	0.0421	CbGpPWpGaD
Midodrine—ADRA1D—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0359	0.0359	CbGpPWpGaD
Midodrine—ADRA1B—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0349	0.0349	CbGpPWpGaD
Midodrine—ADRA1D—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0348	0.0348	CbGpPWpGaD
Midodrine—ADRA1D—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0324	0.0324	CbGpPWpGaD
Midodrine—ADRA1A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.031	0.031	CbGpPWpGaD
Midodrine—ADRA1D—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0302	0.0302	CbGpPWpGaD
Midodrine—ADRA1B—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0298	0.0298	CbGpPWpGaD
Midodrine—ADRA1D—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0293	0.0293	CbGpPWpGaD
Midodrine—ADRA1B—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0289	0.0289	CbGpPWpGaD
Midodrine—ADRA1D—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0273	0.0273	CbGpPWpGaD
Midodrine—ADRA1B—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0269	0.0269	CbGpPWpGaD
Midodrine—ADRA1A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0265	0.0265	CbGpPWpGaD
Midodrine—ADRA1A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0257	0.0257	CbGpPWpGaD
Midodrine—ADRA1B—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.025	0.025	CbGpPWpGaD
Midodrine—ADRA1B—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0243	0.0243	CbGpPWpGaD
Midodrine—ADRA1A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0239	0.0239	CbGpPWpGaD
Midodrine—ADRA1D—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0227	0.0227	CbGpPWpGaD
Midodrine—ADRA1B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0226	0.0226	CbGpPWpGaD
Midodrine—ADRA1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0222	0.0222	CbGpPWpGaD
Midodrine—ADRA1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0216	0.0216	CbGpPWpGaD
Midodrine—ADRA1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0201	0.0201	CbGpPWpGaD
Midodrine—ADRA1D—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0191	0.0191	CbGpPWpGaD
Midodrine—ADRA1B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0189	0.0189	CbGpPWpGaD
Midodrine—ADRA1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0168	0.0168	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.0159	0.0159	CbGpPWpGaD
Midodrine—ADRA1B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0159	0.0159	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.0155	0.0155	CbGpPWpGaD
Midodrine—ADRA1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0141	0.0141	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.0101	0.0101	CbGpPWpGaD
Midodrine—SLC15A1—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00887	0.00887	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00692	0.00692	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00672	0.00672	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00626	0.00626	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00593	0.00593	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00576	0.00576	CbGpPWpGaD
Midodrine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00575	0.00575	CbGpPWpGaD
Midodrine—ADRA1D—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00567	0.00567	CbGpPWpGaD
Midodrine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00558	0.00558	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00536	0.00536	CbGpPWpGaD
Midodrine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.0052	0.0052	CbGpPWpGaD
Midodrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0051	0.0051	CbGpPWpGaD
Midodrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00507	0.00507	CbGpPWpGaD
Midodrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00496	0.00496	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00492	0.00492	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00478	0.00478	CbGpPWpGaD
Midodrine—ADRA1B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00471	0.00471	CbGpPWpGaD
Midodrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00462	0.00462	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00452	0.00452	CbGpPWpGaD
Midodrine—SLC15A1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00451	0.00451	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00445	0.00445	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00439	0.00439	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00439	0.00439	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00437	0.00437	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00425	0.00425	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00421	0.00421	CbGpPWpGaD
Midodrine—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00418	0.00418	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00409	0.00409	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00396	0.00396	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00376	0.00376	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00375	0.00375	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00374	0.00374	CbGpPWpGaD
Midodrine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00364	0.00364	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00364	0.00364	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00339	0.00339	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00333	0.00333	CbGpPWpGaD
Midodrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00323	0.00323	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00323	0.00323	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00312	0.00312	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00301	0.00301	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00286	0.00286	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00277	0.00277	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00255	0.00255	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00248	0.00248	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00237	0.00237	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00232	0.00232	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00231	0.00231	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00225	0.00225	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00212	0.00212	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00211	0.00211	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.0021	0.0021	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00206	0.00206	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	0.00193	0.00193	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00192	0.00192	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00192	0.00192	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00188	0.00188	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00187	0.00187	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00183	0.00183	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00174	0.00174	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00171	0.00171	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.0017	0.0017	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00166	0.00166	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00162	0.00162	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00155	0.00155	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00147	0.00147	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00137	0.00137	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00134	0.00134	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00133	0.00133	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00124	0.00124	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00122	0.00122	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00119	0.00119	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00114	0.00114	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.0011	0.0011	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00108	0.00108	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00103	0.00103	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00101	0.00101	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00098	0.00098	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000913	0.000913	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000867	0.000867	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00072	0.00072	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000639	0.000639	CbGpPWpGaD
